rss
Br J Ophthalmol 2008;92:337-339 doi:10.1136/bjo.2007.125310
  • Original Article
    • Clinical science

Intraocular pressure control after Nd:YAG laser posterior capsulotomy in eyes with glaucoma

  1. J-C Lin1,
  2. L J Katz2,3,
  3. G L Spaeth2,3,
  4. J M Klancnik, Jr2,3
  1. 1
    Department of Ophthalmology, Taipei City Hospital, Ho-Ping Branch, Taipei, Taiwan
  2. 2
    William and Anna Goldberg Glaucoma Service, Wills Eye Hospital, Philadelphia, PA, USA
  3. 3
    Department of Ophthalmology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA, USA
  1. L J Katz, Glaucoma Services, Wills Eye Hospital, 840 Walnut Street, Suite 1110, Philadelphia, PA 19107, USA; ljk22222{at}aol.com
  • Accepted 18 June 2007
  • Published Online First 22 January 2008

Abstract

Background and objectives: To evaluate the long-term intraocular pressure (IOP) control of glaucomatous eyes following Nd:YAG laser capsulotomy.

Materials and methods: We performed a retrospective study of 69 glaucoma patients who underwent an Nd:YAG laser posterior capsulotomy over a 3 year period, following cataract extraction or a combined cataract–glaucoma procedure. All patients had a minimum follow-up period of at least 6 months and a median follow-up period of 2 years. We assessed IOP control, number of glaucoma medications required and whether the patient needed additional glaucoma surgery following the capsulotomy. Based on these outcome measures, we strictly defined “disease progression” as one of the following: an IOP rise of at least 5 mm Hg on two consecutive visits, addition of one or more glaucoma medications and additional glaucoma surgery following the capsulotomy. We calculated Kaplan–Meier event rate curves for these eyes with “disease progression”.

Results: The rate of “disease progression” was 11.6% at 4 months, 20.3% at 6 months, 38.1% at 12 months, 46.1% at 24 months, 52.1% at 36 months and 52.1% at 47 months following the capsulotomy.

Conclusion: Gradual IOP elevation or a need for more aggressive therapy is common in glaucoma patients following Nd:YAG laser posterior capsulotomy. It is unclear whether this progression is related directly to the Nd:YAG laser procedure or whether it is an independent progression of the patient’s glaucoma unrelated to the Nd:YAG laser procedure.

Footnotes

  • Competing interests: None declared.

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All versions of this article:
    1. bjo.2007.125310v1
    2. 92/3/337 most recent

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.